AstraZeneca says U.S. FDA approves rare kidney disease drug
In
Investing.comBy Investing.com10/21/2026, 11:21:10 PM
EXECUTIVE SUMMARY
AstraZeneca says U.S. FDA approves rare kidney disease drug....
Key Takeaways
- AstraZeneca says U.S.
- FDA approves rare kidney disease drug.
Read Complete Original Article
Published originally on Investing.com
Related News
finance10 minutes ago
Timothy E. Johns sells $125,685 in Heritage Insurance stock By Investing.com - Investing.com Australia
Timothy E. Johns sells $125,685 in Heritage Insurance stock By Investing.com Investing.com Australia
finance10 minutes ago
Form 4 Old Second Bancorp Inc: Jill E. York (Director) For: 11 May - Investing.com Australia
Form 4 Old Second Bancorp Inc: Jill E. York (Director) For: 11 May Investing.com Australia
finance10 minutes ago
Mara Holdings CFO Salman Khan sells $126,080 in shares By Investing.com - Investing.com Australia
Mara Holdings CFO Salman Khan sells $126,080 in shares By Investing.com Investing.com Australia
finance20 minutes ago
Great Southern Bancorp earnings missed by $0.12, revenue fell short of estimates
Great Southern Bancorp earnings missed by $0.12, revenue fell short of estimates....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!